Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
RLMD
RELMADA THERAPEUTICS INC
NASDAQ
Biotechnology
$304.61M$2.86-5.15%-$65.70M-3.86x0.06
United States
HSCS
HEARTSCIENCES INC
NASDAQ
Medical Devices
$10.08M$2.101.94%-$9.32M-0.65x-2.84
United States
IMDX
INSIGHT MOLECULAR DIAGNOSTICS INC
NASDAQ
Diagnostics & Research
$52.08M$1.59-10.67%-$39.50M-1.25x-1.90
United States
CTY
CITY THERAPEUTICS INC
NASDAQ
Biotechnology
N/A$16.64-4.91%N/AN/A-0.64
United States
NNVC
NANOVIRICIDES INC
NYSEMKT
Biotechnology
$30.41M$1.192.59%-$11.66M-2.25x0.49
United States
TARS
TARSUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$3.74B$75.95-2.88%-$678.41M-5.00x3.86
United States
CV
CAPSOVISION INC
NASDAQ
Medical Devices
$365.62M$6.822.56%-$28.60M-15.86x0.24
United States
IAM
IAMBIC THERAPEUTICS INC
NASDAQ
Biotechnology
N/A$14.763.80%N/AN/A-0.33
United States
AURA
AURA BIOSCIENCES INC
NASDAQ
Biotechnology
$743.09M$7.14-0.14%-$134.13M-4.35x0.12
United States
AVTX
AVALO THERAPEUTICS INC
NASDAQ
Biotechnology
$387.41M$6.70-6.03%-$88.42M-2.66x0.10
United States
GRAL
GRAIL INC
NASDAQ
Diagnostics & Research
$4.59B$102.10-3.57%-$393.21M-10.82x0.11
United States
MESO
MESOBLAST LTD
NASDAQ
Biotechnology
$1.51B$11.64-2.27%-$33.05M-26.22x0.36
Australia
SOPH
SOPHIA GENETICS SA
NASDAQ
Health Information Services
$639.87M$7.470.27%-$63.38M-6.85x1.70
Switzerland
CLNN
CLENE INC
NASDAQ
Biotechnology
$49.25M$3.426.21%-$21.87M-1.46x-2.50
United States
ZLAB
ZAI LAB LTD
NASDAQ
Biotechnology
$2.49B$22.11-6.03%-$173.69M-11.64x0.82
China
MYGN
MYRIAD GENETICS INC
NASDAQ
Diagnostics & Research
$530.45M$5.53-0.18%-$58.00M-4.10x1.27
United States
VRDN
VIRIDIAN THERAPEUTICS INC
NASDAQ
Biotechnology
$3.42B$30.120.20%-$428.58M-7.80x0.77
United States
UNCY
UNICYCIVE THERAPEUTICS INC
NASDAQ
Biotechnology
$104.19M$3.57-3.51%-$35.56M-2.14x0.33
United States
EBS
EMERGENT BIOSOLUTIONS INC
NYSE
Drug Manufacturers - Specialty & Generic
$282.78M$5.50-1.96%-$106.60M-1.10x2.18
United States
EUDA
EUDA HEALTH HOLDINGS LTD
NASDAQ
Health Information Services
$44.97M$15.02-1.89%-$1.72M-12.41x0.62
Singapore
ENLV
ENLIVEX LTD
NASDAQ
Biotechnology
$1.26M$1.204.35%$4.16B0.00x0.26
Israel
LYCA
LYCIA THERAPEUTICS INC
NASDAQ
Biotechnology
N/A$31.351.39%N/AN/A-0.09
United States
SBFM
SUNSHINE BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.99M$2.41-5.12%-$5.50M-0.01x0.18
United States
QTTB
Q32 BIO INC
NASDAQ
Biotechnology
$255.25M$8.53-1.16%$33.26M2.46x0.03
United States
CVM
CEL SCI CORP
NYSEMKT
Biotechnology
$24.27M$1.38-25.41%-$18.43M-0.82x0.95
United States
AMIX
AUTONOMIX MEDICAL INC
NASDAQ
Medical Devices
$2.23M$1.090.93%-$11.77M-0.08x0.18
United States
SNDA
SONIDA SENIOR LIVING INC
NYSE
Medical Care Facilities
$1.59B$32.42-0.46%$47.41M-6.06x2.03
United States
SLXN
SILEXION THERAPEUTICS CORP
NASDAQ
Biotechnology
$935.32k$1.44-12.73%-$13.51M-0.31x1.30
Israel
CAMP
CAMP4 THERAPEUTICS CORP
NASDAQ
Biotechnology
$257.29M$4.102.50%-$118.38M-1.92x0.25
United States
IRON
DISC MEDICINE INC
NASDAQ
Biotechnology
$3.55B$77.981.84%-$237.56M-12.30x0.16
United States
DFTX
DEFINIUM THERAPEUTICS INC
NASDAQ
Biotechnology
$3.99B$29.12-0.88%-$332.59M-9.64x0.11
Canada
ABCL
ABCELLERA BIOLOGICS INC
NASDAQ
Biotechnology
$3.60B$11.02-0.09%-$147.31M-22.96x0.41
Canada
FRMM
FORUM MARKETS INC
NASDAQ
Biotechnology
$30.77M$2.20-5.98%-$303.27M-0.22x0.22
United States
RXST
RXSIGHT INC
NASDAQ
Medical Devices
$210.07M$5.013.73%-$49.60M-3.91x0.34
United States
AVR
ANTERIS TECHNOLOGIES GLOBAL CORP
NASDAQ
Medical Instruments & Supplies
$507.94M$5.21-2.07%-$105.92M-3.24x0.16
United States
NAGE
NIAGEN BIOSCIENCE INC
NASDAQ
Biotechnology
$153.64M$1.94-4.90%$12.83M14.92x0.31
United States
SPTX
SEAPORT THERAPEUTICS INC
NASDAQ
Biotechnology
$980.14M$18.310.77%N/AN/A0.05
United States
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS INC
NASDAQ
Biotechnology
$144.85M$1.81-6.96%-$170.77M-0.00x0.18
United States
DAVI
DAVION HEALTHCARE PLC
NASDAQ
Medical Instruments & Supplies
N/A$1.073.88%-$968.25k-30.57x0.02
Ireland
NYXH
NYXOAH SA
NASDAQ
Medical Instruments & Supplies
$86.36M$0.86-4.11%-$67.56M-0.45x1.19
Belgium
CTMX
CYTOMX THERAPEUTICS INC
NASDAQ
Biotechnology
$409.85M$1.88-3.09%-$78.95M-3.76x0.28
United States
INO
INOVIO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$316.55M$1.693.68%-$68.09M-3.13x-2.77
United States
OPK
OPKO HEALTH INC
NASDAQ
Diagnostics & Research
$1.25B$1.694.32%-$45.33M-8.89x0.69
United States
FOCL
EDAP TMS SA
NASDAQ
Medical Distribution
$146.38M$3.109.15%N/A-2.65x2.08
France
RAPP
RAPPORT THERAPEUTICS INC
NASDAQ
Biotechnology
$1.39B$23.40-1.52%-$147.21M-7.41x0.07
United States
ACOG
ALPHA COGNITION INC
NASDAQ
Biotechnology
$189.56M$8.608.59%-$28.19M-6.32x0.30
Canada
CLPT
CLEARPOINT NEURO INC
NASDAQ
Medical Devices
$247.14M$7.71-1.91%-$25.20M-6.43x3.13
United States
PYXS
PYXIS ONCOLOGY INC
NASDAQ
Biotechnology
$168.65M$1.41-2.08%-$80.72M-1.08x0.86
United States
CAI
CARIS LIFE SCIENCES INC
NASDAQ
Biotechnology
$5.59B$19.50-2.21%$168.30M11.75x0.96
United States
LGND
LIGAND PHARMACEUTICALS INC
NASDAQ
Biotechnology
$5.98B$298.711.67%$98.44M112.72x1.33
United States
BKD
BROOKDALE SENIOR LIVING INC
NYSE
Medical Care Facilities
$2.06B$8.59-2.39%$507.90M-53.69x-152.06
United States
SCTX
SCRIBE THERAPEUTICS INC
NASDAQ
Biotechnology
$266.07M$14.05-10.91%N/AN/A0.50
United States
MDAI
SPECTRAL AI INC
NASDAQ
Medical Devices
$43.45M$1.350.37%-$7.93M-4.50x-2.07
United States
FBLG
FIBROBIOLOGICS INC
NASDAQ
Biotechnology
$7.55M$0.84-6.67%-$15.44M-0.28x2.73
United States
PTHS
PELTHOS THERAPEUTICS INC
NYSEMKT
Biotechnology
$27.91M$7.103.80%-$71.07M-0.29x-21.82
United States
SANA
SANA BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$554.32M$1.85-1.60%-$128.21M-3.49x1.09
United States
QNTM
QUANTUM BIOPHARMA LTD
NASDAQ
Biotechnology
$13.05M$1.52-4.40%-$13.60M-0.50x0.64
Canada
DTIL
PRECISION BIOSCIENCES INC
NASDAQ
Biotechnology
$198.34M$7.100.71%-$34.78M24.48x1.33
United States
GLSI
GREENWICH LIFESCIENCES INC
NASDAQ
Biotechnology
$302.08M$20.5810.05%-$23.34M-12.55x-4.38
United States
ALHC
ALIGNMENT HEALTHCARE INC
NASDAQ
Healthcare Plans
$1.41B$6.72-11.81%$77.06M44.80x3.68
United States
SNWV
SANUWAVE HEALTH INC
NASDAQ
Medical Devices
$14.71M$1.710.59%$6.29M5.70x10.41
United States
FULC
FULCRUM THERAPEUTICS INC
NASDAQ
Biotechnology
$284.14M$3.72-0.80%-$75.44M-3.58x0.03
United States
CNXU
CONEXEU SCIENCES INC
NASDAQ
Biotechnology
$66.43M$2.3617.75%N/AN/A0.22
United States
GH
GUARDANT HEALTH INC
NASDAQ
Diagnostics & Research
$19.64B$145.141.30%-$441.45M-39.44x-7.83
United States
TRAX
FIRST TRACKS BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$1.87B$44.502.13%N/AN/A0.13
United States
AUTL
AUTOLUS THERAPEUTICS PLC
NASDAQ
Biotechnology
$282.32M$1.06-2.75%-$205.67M-1.09x18.09
United Kingdom
VRXA
VERAXA BIOTECH AG
NASDAQ
Biotechnology
$145.65M$1.03-0.96%-$80.06M-0.18x-6.13
United States
ETRA
ELECTRA THERAPEUTICS INC
NASDAQ
Biotechnology
$529.97M$8.430.96%N/AN/A0.05
United States
QURE
UNIQURE NV
NASDAQ
Biotechnology
$1.42B$20.30-2.31%-$159.98M-5.78x2.19
Netherlands
CDXS
CODEXIS INC
NASDAQ
Biotechnology
$126.04M$1.157.48%-$4.94M-6.05x1.82
United States
KURA
KURA ONCOLOGY INC
NASDAQ
Biotechnology
$674.39M$7.34-2.00%-$289.96M-2.22x30.54
United States
ARVN
ARVINAS INC
NASDAQ
Biotechnology
$443.01M$6.77-0.81%-$4.20M-96.64x0.18
United States
BDSX
BIODESIX INC
NASDAQ
Diagnostics & Research
$93.14M$8.40-5.41%-$13.46M-3.11x9.83
United States
OBIO
ORCHESTRA BIOMED HOLDINGS INC
NASDAQ
Biotechnology
$587.14M$7.467.03%-$50.12M-9.95x11.44
United States
ACRV
ACRIVON THERAPEUTICS INC
NASDAQ
Biotechnology
$66.94M$1.569.09%-$71.23M-0.85x0.21
United States
IMVT
IMMUNOVANT INC
NASDAQ
Biotechnology
$6.86B$33.17-0.12%-$509.77M-12.96x0.16
United States
PROF
PROFOUND MEDICAL CORP
NASDAQ
Medical Devices
$253.09M$6.91-2.40%-$23.23M-10.38x0.37
Canada
GNPX
GENPREX INC
NASDAQ
Biotechnology
$2.28M$1.712.33%-$16.94M0.02x0.28
United States
HYFT
MINDWALK HOLDINGS CORP
NASDAQ
Biotechnology
$42.04M$0.90-0.77%-$11.82M-3.38x1.51
Canada
PRCT
PROCEPT BIOROBOTICS CORP
NASDAQ
Medical Devices
$1.45B$25.185.89%-$115.96M-12.47x0.44
United States
AVBP
ARRIVENT BIOPHARMA INC
NASDAQ
Biotechnology
$563.78M$10.901.96%-$169.07M-3.03x0.06
United States
MOBI
MOBIA MEDICAL INC
NASDAQ
Medical Devices
$434.26M$13.033.33%N/AN/A0.15
United States
TNON
TENON MEDICAL INC
NASDAQ
Medical Devices
$2.84M$1.06-15.20%-$14.66M-0.03x0.76
United States
COAG
HEMAB THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$1.83B$39.150.23%N/AN/A0.03
United States
LTGO
LATIGO BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$882.44M$13.31-3.27%N/AN/A0.04
United States
BRVE
BRAVEHEART BIO INC
NASDAQ
Biotechnology
$1.67B$18.53-1.33%N/AN/A0.03
United States
CRSP
CRISPR THERAPEUTICS AG
NASDAQ
Biotechnology
$3.90B$40.190.10%-$435.15M-8.51x0.55
Switzerland
AVLN
AVALYN PHARMA INC
NASDAQ
Biotechnology
$1.23B$27.69-0.82%N/AN/A0.08
United States
KLRA
KAILERA THERAPEUTICS INC
NASDAQ
Biotechnology
$1.53B$11.79-3.36%N/AN/A0.05
United States
KARD
KARDIGAN INC
NASDAQ
Biotechnology
$1.15B$12.32-6.60%N/AN/A0.13
United States
MNKD
MANNKIND CORP
NASDAQ
Biotechnology
$1.31B$4.070.00%-$1.04M-17.70x-20.39
United States
TRDA
ENTRADA THERAPEUTICS INC
NASDAQ
Biotechnology
$196.93M$5.031.41%-$157.99M-1.31x0.35
United States
PMI
PICARD MEDICAL INC
NYSEMKT
Medical Devices
$17.14M$6.44-6.80%-$19.12M4.29x5.82
United States
KLRS
KALARIS THERAPEUTICS INC
NASDAQ
Biotechnology
$32.61M$1.37-4.20%-$43.19M-0.74x0.88
United States
TIL
INSTIL BIO INC
NASDAQ
Biotechnology
$36.83M$5.430.56%-$13.50M-1.79x0.91
United States
PRTA
PROTHENA CORP PUBLIC LTD CO
NASDAQ
Biotechnology
$428.77M$8.351.09%-$20.24M-17.77x0.06
Ireland
EDIT
EDITAS MEDICINE INC
NASDAQ
Biotechnology
$273.18M$1.77-3.01%-$73.61M-3.16x1.60
United States
SNDX
SYNDAX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$770.64M$8.56-6.96%-$161.59M-3.63x-41.32
United States
VTVT
VTV THERAPEUTICS INC
NASDAQ
Biotechnology
$65.11M$16.23-6.13%-$7.67M-36.07x0.13
United States
NXTC
NEXTCURE INC
NASDAQ
Biotechnology
$31.53M$6.892.76%-$39.28M-1.02x0.76
United States
1...456...11

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
607-0.52%-6.81%+0.95%-95.50%17.98x4.91x-22.46%-6.75%-2.33%+87.06%Strong Buy
50+0.97%-2.97%+2.99%+23.27%30.88x4.64x+579.51%+6.82%+12.38%+5.76%Buy
20-2.15%-3.57%+7.18%+23.12%42.06x8.36x+13.87%+10.55%+18.49%+5.76%Buy
73+0.82%-1.41%+5.21%-99.94%71.46x2.54x+6.57%+2.25%+23.87%+181.30%Strong Buy
10-8.43%-8.95%-7.71%+26.62%14.64x2.17x+14.09%+4.29%+10.14%+23.10%Buy
49-1.09%-7.98%-3.10%-68.85%25.37x4.01x+9.20%+4.48%+9.90%+29.67%Buy
47-3.38%-5.42%+1.87%-63.35%15.51x5.72x-34.26%+7.78%+16.63%+14.49%Buy
132+0.58%-2.97%+5.38%-90.83%25.19x3.27x+9.39%+5.13%+9.43%+21.74%Buy
8-0.40%-0.06%+6.18%+18.61%28.73x-243.59x-63.96%+4.17%+25.32%+5.93%Buy
51+0.64%-2.23%+4.32%+10.92%25.57x3.60x+9.55%+7.24%+12.15%+12.07%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bausch Health Companies (NYSE:BHC)


Bausch Health Companies (NYSE:BHC) is the #1 top healthcare stock out of 1047 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 9, which is -18 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 3 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock return 41.26% over the past year, overperforming other healthcare stocks by 140 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 3.09% from Bausch Health Companies's current stock price of $8.73.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Oscar Health (NYSE:OSCR)


Oscar Health (NYSE:OSCR) is the #2 top healthcare stock out of 1047 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Oscar Health (NYSE:OSCR) is: Value: A, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Oscar Health (NYSE:OSCR) has a Due Diligence Score of 54, which is 27 points higher than the healthcare sector average of 27. It passed 18 out of 33 due diligence checks and has strong fundamentals. Oscar Health has seen its stock return 87.42% over the past year, overperforming other healthcare stocks by 186 percentage points.

Oscar Health has an average 1 year price target of $37.00, an upside of 34.2% from Oscar Health's current stock price of $27.57.

Oscar Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Oscar Health, 25% have issued a Strong Buy rating, 12.5% have issued a Buy, 50% have issued a Hold, while 12.5% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Regeneron Pharmaceuticals (NASDAQ:REGN)


Regeneron Pharmaceuticals (NASDAQ:REGN) is the #3 top healthcare stock out of 1047 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 30.36% over the past year, overperforming other healthcare stocks by 129 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $930.74, a downside of -1.56% from Regeneron Pharmaceuticals's current stock price of $945.53.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 23 analysts covering Regeneron Pharmaceuticals, 65.22% have issued a Strong Buy rating, 4.35% have issued a Buy, 30.43% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 80 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)


Rallybio (NASDAQ:RLYB) has an annual dividend yield of 88.86%, which is 85 percentage points higher than the healthcare sector average of 3.58%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Supernus (NASDAQ:SUPN)


Supernus (NASDAQ:SUPN) has an annual dividend yield of 28.07%, which is 24 percentage points higher than the healthcare sector average of 3.58%.

Supernus's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)


Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 22.83%, which is 19 percentage points higher than the healthcare sector average of 3.58%.

Cumberland Pharmaceuticals's dividend payout ratio of 65.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.77% in the last day, and down -4.74% over the last week. Iridex was the among the top losers in the healthcare sector, dropping -28.57% yesterday.

Iridex shares are trading lower after the company reported worse-than-expected Q3 financial results and lowered its FY26 sales guidance below analyst estimates.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 53.7% in the past year. It has overperformed other stocks in the healthcare sector by 152 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -2.59% in the past year. It has overperformed other stocks in the healthcare sector by 96 percentage points.

3. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -57.14% in the past year. It has overperformed other stocks in the healthcare sector by 41 percentage points.

Are healthcare stocks a good buy now?

57.34% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 41.15% over the next year.

5.19% of healthcare stocks have a Zen Rating of A (Strong Buy), 14.4% of healthcare stocks are rated B (Buy), 45.78% are rated C (Hold), 25.94% are rated D (Sell), and 8.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 32.87x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.